97 related articles for article (PubMed ID: 12596013)
1. [Experimental microvascular and clotting changes--significance for acute stroke therapy].
Wagner S; Hamann GF
Nervenarzt; 2003 Feb; 74(2):123-32. PubMed ID: 12596013
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion.
Trinkl A; Vosko MR; Wunderlich N; Dichgans M; Hamann GF
Eur J Neurosci; 2006 Jul; 24(2):520-6. PubMed ID: 16836638
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase induction by EMMPRIN in experimental focal cerebral ischemia.
Burggraf D; Liebetrau M; Martens HK; Wunderlich N; Jäger G; Dichgans M; Hamann GF
Eur J Neurosci; 2005 Jul; 22(1):273-7. PubMed ID: 16029217
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion.
Hamann GF; Okada Y; del Zoppo GJ
J Cereb Blood Flow Metab; 1996 Nov; 16(6):1373-8. PubMed ID: 8898714
[TBL] [Abstract][Full Text] [Related]
6. rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia.
Burggraf D; Martens HK; Dichgans M; Hamann GF
Brain Res; 2007 Aug; 1164():55-62. PubMed ID: 17644075
[TBL] [Abstract][Full Text] [Related]
7. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic transformation of cerebral infarction--possible mechanisms.
Hamann GF; del Zoppo GJ; von Kummer R
Thromb Haemost; 1999 Sep; 82 Suppl 1():92-4. PubMed ID: 10695495
[TBL] [Abstract][Full Text] [Related]
10. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
Zhang L; Zhang ZG; Ding GL; Jiang Q; Liu X; Meng H; Hozeska A; Zhang C; Li L; Morris D; Zhang RL; Lu M; Chopp M
Circulation; 2005 Nov; 112(22):3486-94. PubMed ID: 16316970
[TBL] [Abstract][Full Text] [Related]
11. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice.
Chen TY; Lee MY; Chen HY; Kuo YL; Lin SC; Wu TS; Lee EJ
J Pineal Res; 2006 Apr; 40(3):242-50. PubMed ID: 16499561
[TBL] [Abstract][Full Text] [Related]
12. Critical role of microvasculature basal lamina in ischemic brain injury.
Wang CX; Shuaib A
Prog Neurobiol; 2007 Oct; 83(3):140-8. PubMed ID: 17868971
[TBL] [Abstract][Full Text] [Related]
13. Different therapy options protecting microvasculature after experimental cerebral ischaemia and reperfusion.
Burggraf D; Vosko MR; Schubert M; Stassen JM; Hamann GF
Thromb Haemost; 2010 May; 103(5):891-900. PubMed ID: 20216985
[TBL] [Abstract][Full Text] [Related]
14. Stroke biomarkers: Can they help us to guide stroke thrombolysis?
Montaner J
Drug News Perspect; 2006 Nov; 19(9):523-32. PubMed ID: 17220957
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
Kelly MA; Shuaib A; Todd KG
Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia.
Burggraf D; Martens HK; Jäger G; Hamann GF
Thromb Haemost; 2003 Jun; 89(6):1072-80. PubMed ID: 12783121
[TBL] [Abstract][Full Text] [Related]
17. Evaluating therapeutic targets for reperfusion-related brain hemorrhage.
Maier CM; Hsieh L; Crandall T; Narasimhan P; Chan PH
Ann Neurol; 2006 Jun; 59(6):929-38. PubMed ID: 16673393
[TBL] [Abstract][Full Text] [Related]
18. Reperfusion seizures: a manifestation of cerebral reperfusion injury after administration of recombinant tissue plasminogen activator for acute ischemic stroke.
Hafeez F; Razzaq MA; Levine RL; Ramirez MA
J Stroke Cerebrovasc Dis; 2007; 16(6):273-7. PubMed ID: 18035246
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent.
Kahles T; Foerch C; Sitzer M; Schroeter M; Steinmetz H; Rami A; Neumann-Haefelin T
Vascul Pharmacol; 2005 Oct; 43(4):254-9. PubMed ID: 16185938
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms for the development of intracranial hemorrhage. Possible implications for thrombolysis in cerebral infarct].
Hamann GF; del Zoppo GJ; von Kummer R
Nervenarzt; 1999 Dec; 70(12):1116-20. PubMed ID: 10637820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
